Literature DB >> 28219791

Bone marrow mesenchymal stem cells-conditioned medium enhances vascular remodeling after stroke in type 2 diabetic rats.

Jie Xiang1, Jinxia Hu2, Tong Shen2, Bin Liu3, Fang Hua2, Kun Zan2, Jie Zu2, Guiyun Cui4, Xinchun Ye5.   

Abstract

Our previous studies have found that stem cells conditioned medium (CM) facilitated functional recovery after stroke in non-diabetics. However, whether bone marrow stromal cells conditioned medium (BMSCs-CM) treatment after stroke in type 2 diabetic (T2DM) rats improve functional outcomes remains unclear. T2DM rats were induced and subjected to stroke then treated with or without BMSCs-CM. Functional outcomes and blood-brain barrier (BBB) leakage were performed, the expression of Angiopoietin (Ang) 1 and tyrosine kinase (Tie) 2 were also assessed. Our results showed that BMSCs-CM treatment significantly improved functional outcomes, decreased BBB leakage and the expression of Ang1 and Tie2 were also changed after BMSCs-CM treatment in type 2 diabetes after stroke. In conclusion, enhanced expression of Ang1 and Tie2 in ischemic brain after BMSCs-CM treatment of stroke may contribute to the improved functional recovery after stroke in type 2 diabetic rats.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Angiopoietin 1; Bone marrow stromal cells; Ischemic stroke; Type 2 diabetes mellitus; Tyrosine kinase 2

Mesh:

Substances:

Year:  2017        PMID: 28219791     DOI: 10.1016/j.neulet.2017.02.040

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  6 in total

Review 1.  Paracrine Effects of Mesenchymal Stem Cells in Ischemic Stroke: Opportunities and Challenges.

Authors:  Afsaneh Asgari Taei; Pariya Khodabakhsh; Sanaz Nasoohi; Maryam Farahmandfar; Leila Dargahi
Journal:  Mol Neurobiol       Date:  2022-08-03       Impact factor: 5.682

2.  Mesenchymal Stem Cell-Conditioned Medium Reduces Disease Severity and Immune Responses in Inflammatory Arthritis.

Authors:  Alasdair G Kay; Grace Long; George Tyler; Andrei Stefan; Stephen J Broadfoot; Anna M Piccinini; Jim Middleton; Oksana Kehoe
Journal:  Sci Rep       Date:  2017-12-21       Impact factor: 4.379

Review 3.  Blood-brain barrier dysfunction in ischemic stroke and diabetes: the underlying link, mechanisms and future possible therapeutic targets.

Authors:  Piyawadee Wicha; Srijit Das; Pasuk Mahakkanukrauh
Journal:  Anat Cell Biol       Date:  2021-06-30

Review 4.  Mesenchymal Stem Cells: Therapeutic Mechanisms for Stroke.

Authors:  Yuchen Zhang; Naijun Dong; Huanle Hong; Jingxuan Qi; Shibo Zhang; Jiao Wang
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 5.923

5.  The Effects and Underlying Mechanisms of Cell Therapy on Blood-Brain Barrier Integrity After Ischemic Stroke.

Authors:  Li Gao; Zhenghong Song; Jianhua Mi; Pinpin Hou; Chong Xie; Jianquan Shi; Yansheng Li; Anatol Manaenko
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

6.  Autologous treatment for ALS with implication for broad neuroprotection.

Authors:  Daehwan Kim; Subin Kim; Ashley Sung; Neetika Patel; Nathan Wong; Michael J Conboy; Irina M Conboy
Journal:  Transl Neurodegener       Date:  2022-03-11       Impact factor: 8.014

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.